NeuroBo Pharmaceuticals, Inc. (NRBO)
NASDAQ: NRBO · Real-Time Price · USD
2.370
-0.010 (-0.42%)
At close: Nov 22, 2024, 4:00 PM
2.430
+0.060 (2.53%)
After-hours: Nov 22, 2024, 4:07 PM EST
NeuroBo Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -27.73 | -12.47 | -13.97 | -15.28 | -29.68 | -21.31 | |
| Depreciation & Amortization | 0.02 | 0.01 | 0.02 | 0.05 | 0.05 | 0.02 | |
| Other Amortization | - | - | 2.19 | - | - | - | |
| Loss (Gain) From Sale of Assets | - | - | 0.08 | - | - | - | |
| Asset Writedown & Restructuring Costs | - | - | 8.21 | - | 17.34 | 12.15 | |
| Stock-Based Compensation | 0.48 | 0.22 | 0.85 | 0.66 | 0.7 | 0.12 | |
| Other Operating Activities | -0.15 | -2.95 | -7.93 | 0.02 | 0.02 | 1.24 | |
| Change in Accounts Payable | -1.14 | 0.11 | -0.2 | -1.16 | 1.12 | -1.05 | |
| Change in Other Net Operating Assets | 5.85 | 4.28 | -0.97 | 0.58 | -0.31 | 1.79 | |
| Operating Cash Flow | -22.68 | -10.8 | -11.71 | -15.13 | -10.76 | -7.04 | |
| Capital Expenditures | -0.02 | -0.05 | - | -0 | -0 | -0.21 | |
| Sale of Property, Plant & Equipment | - | - | 0.01 | - | - | - | |
| Cash Acquisitions | - | - | - | -0.58 | 0.07 | -5.84 | |
| Investing Cash Flow | -0.02 | -0.05 | 0.01 | -0.59 | 0.07 | -6.06 | |
| Issuance of Common Stock | 20 | - | 32.25 | 24.12 | 7.55 | 0 | |
| Other Financing Activities | -1.47 | -0.08 | -3.57 | -2.09 | -0.7 | -0.07 | |
| Financing Cash Flow | 18.52 | -0.08 | 28.68 | 22.03 | 6.86 | 24.17 | |
| Foreign Exchange Rate Adjustments | - | - | - | -0.01 | 0 | 0.01 | |
| Net Cash Flow | -4.17 | -10.93 | 16.98 | 6.3 | -3.83 | 11.08 | |
| Free Cash Flow | -22.69 | -10.85 | -11.71 | -15.14 | -10.77 | -7.25 | |
| Free Cash Flow Per Share | -3.51 | -2.14 | -36.41 | -156.98 | -159.36 | -333.21 | |
| Cash Interest Paid | - | - | - | - | - | 0 | |
| Levered Free Cash Flow | -13.14 | -15.55 | 4.24 | -10 | -5.77 | -2.58 | |
| Unlevered Free Cash Flow | -13.14 | -15.55 | 5.61 | -10 | -5.77 | -2.5 | |
| Change in Net Working Capital | -4.44 | 5.8 | -9.68 | 1.14 | -1.23 | -2.59 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.